Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Deferred Taxes (2020 - 2025)

Viemed Healthcare posted quarterly Deferred Taxes of $380000.0 for Q4 2025, up 214.11% year-on-year from $120975.1 in Q4 2024, and down 91.9% on a QoQ basis from $4.7 million in Q3 2025.

Viemed Healthcare (VMD) has 6 years of Deferred Taxes data on file, last reported at $380000.0 in Q4 2025.

  • For the quarter ending Q4 2025, Deferred Taxes rose 214.11% year-over-year to $380000.0; the trailing twelve-month figure through Dec 2025 stood at $1.2 million (up 132.03% YoY), and the FY2025 full-year result was $3.1 million, up 180.96% from the prior year.
  • Deferred Taxes for Q4 2025 stood at $380000.0, down from $4.7 million in the prior quarter.
  • Across five years, Deferred Taxes topped out at $4.7 million in Q3 2025 and bottomed at -$3.5 million in Q3 2024.
  • The 5-year median for Deferred Taxes is $380000.0 (2025), against an average of $417000.0.
  • The widest annual swing landed in 2021, when Deferred Taxes jumped 505.6%; it then sank 5213.64% in 2024.
  • A 5-year view of Deferred Taxes shows it stood at $1.5 million in 2021, then plunged by 32.09% to $1.0 million in 2022, then plunged by 164.74% to -$648000.0 in 2023, then soared by 48.61% to -$333000.0 in 2024, then jumped by 214.11% to $380000.0 in 2025.
  • The last three Deferred Taxes figures came in at $380000.0 (Q4 2025), $4.7 million (Q3 2025), and -$333000.0 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -33.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -101.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -351.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -9.40 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 300,000.00
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -16.70 Mn
10 Viemed Healthcare 373.53 Mn 365.70 Mn 42.83 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 380,000.00
Sep 30, 2025 4.69 Mn
Dec 31, 2024 -333,000.00
Sep 30, 2024 -3.51 Mn
Dec 31, 2023 -648,000.00
Sep 30, 2023 -66,000.00
Mar 31, 2023 -725,000.00
Dec 31, 2022 1.00 Mn
Mar 31, 2022 745,000.00
Dec 31, 2021 1.47 Mn
Sep 30, 2021 1.41 Mn
Jun 30, 2021 1.23 Mn
Mar 31, 2021 -222,000.00
Dec 31, 2020 -1.14 Mn
Sep 30, 2020 232,000.00
Jun 30, 2020 -7.83 Mn